Acute and Subchronic Oral Safety Profiles of the Sudarshana Suspension

Show simple item record

dc.contributor.author Weerakoon, W.A.S.S.
dc.contributor.author Perera, P.K.
dc.contributor.author Samarasinghe, K.
dc.contributor.author Gunasekera, D.
dc.contributor.author Suresh, T.S.
dc.date.accessioned 2024-09-03T06:17:34Z
dc.date.available 2024-09-03T06:17:34Z
dc.date.issued 2020
dc.identifier.citation Weerakoon, W.A.S.S., Perera, P.K., Samarasinghe, K., Gunasekera, D., and Suresh, T.S. (2020). Acute and Subchronic Oral Safety Profiles of the Sudarshana Suspension. Evidence-Based Complementary and Alternative Medicine. https://doi.org/10.1155/2020/2891058 en_US
dc.identifier.issn 1741-427X
dc.identifier.uri https://doi.org/10.1155/2020/2891058
dc.identifier.uri http://archive.cmb.ac.lk:8080/xmlui/handle/70130/7317
dc.description.abstract Sudarshana powder (SP) is an Ayurvedic preparation, which contains 53 herbal ingredients along with 50% of Andrographis paniculata and is clinically used with bees honey. +is study was aimed to determine the safety pro4le of the SP, and its novel preparation Sudarshana suspension (SS) on male Wistar rats and tolerance studies were conducted for healthy adult volunteers. Acute and subacute toxicity studies of the SS and hot water extract of SP were assessed in Wistar rats by observing the general behavior, analyzing biochemical and haematological parameters, and pathological observation. Healthy consented adult volunteers (n � 35) of either sex were selected, and tolerance studies of SS were tested by measuring the biochemical and haematological parameters. +ere were no signi4cant (p>0.05) changes observed in the treated animals with SS and hot water extract of SP compared with control in body weights, food intake, and water consumption as well as the biochemical and haematological parameters. Histopathological studies revealed no signi4cant (p>0.05) changes in the liver, heart, and kidney tissues. +e experimental results suggest that novel formulation SS was potentially safe for chronic administration in rats, and no signi4cant di8erences (p>0.05) were observed in tested parameters on day 3 and day 8 when compared to the day 0 (baseline) values in healthy volunteers. Healthy volunteers did not report any adverse e8ects or any other complications during the treatment period and the follow-up period. +erefore, it can be concluded that the novel preparation Sudarshana suspension does not cause any signi4cant toxic e8ects on the blood parameters in animal and human models. en_US
dc.language.iso en en_US
dc.publisher Evidence-Based Complementary and Alternative Medicine en_US
dc.subject Sudarshana Suspension en_US
dc.subject Oral Safety en_US
dc.title Acute and Subchronic Oral Safety Profiles of the Sudarshana Suspension en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account